Kimberly-Clark Reports Q2 Results, Lowers Full-Year Outlook Due to China Diaper Allegations
KMB sits 15% above its 52-week low of $92.42.
Summary
Kimberly-Clark reported Q2 adjusted EPS growth but lowered its full-year outlook, projecting a decline in adjusted EPS attributable to the company, primarily due to a significant sales disruption in China's diaper market.
Updates
· SEC 10-Q — The IFP transaction closed on July 1, 2026, with Suzano acquiring a 51% interest for approximately $1.7 billion. Kimberly-Clark borrowed about $1.3 billion under the IFP Term Loan Facility on June 29, 2026.
Key Events · Earnings and Guidance · KMB
-
Q2 Adjusted EPS Increased
Adjusted diluted EPS from continuing operations rose 10.4% to $1.80, and adjusted EPS attributable to Kimberly-Clark increased 10.4% to $2.12 for the second quarter.
-
China Diaper Allegations Impact Sales
False allegations regarding diaper quality in China negatively impacted Q2 organic sales growth by approximately 50 basis points and are expected to further affect near-term sales and profits.
-
Full-Year Outlook Lowered
The company now expects 2026 organic sales growth to be approximately 100 basis points below its weighted average category growth (currently 2%), and adjusted EPS attributable to Kimberly-Clark is projected to see a low single-digit decline on a constant-currency basis.
-
Strategic Initiatives Progressing
Kimberly-Clark successfully launched its strategic joint venture with Suzano (Arbex) and confirmed its pending acquisition of Kenvue remains on track to close by year-end.
Analysis · KMB · Manufacturing
Kimberly-Clark reported mixed second-quarter results, with adjusted EPS from continuing operations increasing by 10.4%. However, the company's full-year outlook has been lowered, primarily due to a significant disruption from false allegations regarding diaper quality in the China market. This issue negatively impacted Q2 organic sales by approximately 50 basis points and is expected to reduce full-year organic sales growth by about 100 basis points, leading to a projected low single-digit decline in adjusted EPS attributable to Kimberly-Clark. While strategic initiatives like the Arbex joint venture and Kenvue acquisition are progressing, the revised guidance and specific market headwind are material concerns for investors.
How filings like this one have moved
In the 30 days to Nov 2, 2026, 40.4% of the 1069 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.35%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, KMB was trading at $106.70 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $35.7B. The 52-week trading range was $92.42 to $137.46. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.